CINECA IRIS Institutional Research Information System

NICOLAZZO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.002
SA - Sud America 430
NA - Nord America 286
EU - Europa 141
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 20
Totale 1.940
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 329
US - Stati Uniti d'America 243
VN - Vietnam 226
SG - Singapore 224
HK - Hong Kong 206
CN - Cina 158
KR - Corea 75
BD - Bangladesh 70
IT - Italia 51
AR - Argentina 49
FR - Francia 33
MX - Messico 27
EC - Ecuador 18
CO - Colombia 13
DE - Germania 13
ID - Indonesia 10
PL - Polonia 10
RU - Federazione Russa 9
GB - Regno Unito 8
ZA - Sudafrica 8
CL - Cile 6
MA - Marocco 6
IQ - Iraq 5
PY - Paraguay 5
CA - Canada 4
IN - India 4
PK - Pakistan 4
UA - Ucraina 4
UY - Uruguay 4
UZ - Uzbekistan 4
VE - Venezuela 4
JM - Giamaica 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
DO - Repubblica Dominicana 2
JP - Giappone 2
NI - Nicaragua 2
PE - Perù 2
TW - Taiwan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
FI - Finlandia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
MY - Malesia 1
OM - Oman 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SE - Svezia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TR - Turchia 1
UG - Uganda 1
Totale 1.879
Salva come PNG Salva come JPEG
Città #
Hong Kong 205
Ho Chi Minh City 87
Seoul 75
Singapore 58
Ashburn 47
Hanoi 41
Beijing 40
São Paulo 26
Chicago 24
San Jose 21
Mexico City 18
New York 15
Dallas 13
Rome 12
Haiphong 11
Hillsboro 11
Warsaw 10
Belo Horizonte 9
Rio de Janeiro 9
Biên Hòa 8
Frankfurt am Main 8
Los Angeles 8
Guayaquil 7
Milan 7
Thái Bình 7
Buffalo 6
Hải Dương 6
Concordia 5
Da Nang 5
Fortaleza 5
Porto Alegre 5
Bexley 4
Brasília 4
Brooklyn 4
Curitiba 4
Huế 4
Osasco 4
Ribeirão Preto 4
Salvador 4
Santa Clara 4
Tashkent 4
Valparaíso de Goiás 4
Belém 3
Buenos Aires 3
Casablanca 3
Guarulhos 3
Ha Long 3
Ipatinga 3
Jakarta 3
Jundiaí 3
Quito 3
São José dos Campos 3
Thái Nguyên 3
Americana 2
Angra dos Reis 2
Arapongas 2
Araçatuba 2
Bari 2
Barretos 2
Basra 2
Belford Roxo 2
Blumenau 2
Bogotá 2
Bắc Giang 2
Bắc Ninh 2
Camacan 2
Camaçari 2
Campinas 2
Canoas 2
Caracas 2
Castelfranco Emilia 2
Catanduva 2
Corrientes 2
Criciúma 2
Cruz Alta 2
Dhaka 2
Fernando de la Mora 2
Florianópolis 2
Guaraciaba 2
Itabira 2
Itu 2
Johannesburg 2
João Pessoa 2
Juiz de Fora 2
La Plata 2
Lima 2
Limeira 2
Managua 2
Medellín 2
Miami 2
Montevideo 2
Natal 2
Niterói 2
Norcross 2
Nova Iguaçu 2
Novo Hamburgo 2
Ouricuri 2
Paraisópolis 2
Pelotas 2
Petrópolis 2
Totale 980
Salva come PNG Salva come JPEG
Nome #
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer 62
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 58
A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance 52
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors 52
Evolution of Neo-RAS-WT in Circulating Tumor DNA from First-Line to Subsequent Therapies in Metastatic Colorectal Cancer 50
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer 49
Is cancer an intelligent species? 49
Blood Extracellular Vesicles Beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients 47
RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study 46
The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis 42
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 40
Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: Comparative pre- and post-operative analysis and association with prognosis 40
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile 39
Circulating methylated dna to monitor the dynamics of ras mutation clearance in plasma from metastatic colorectal cancer patients 39
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 38
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments 38
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria? 36
Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer 36
About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients 35
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) 35
Signet ring cell carcinoma of the urinary bladder presenting with carcinocythemia and skeletal metastasis: A case report 34
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? 34
Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer 33
Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer 33
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 32
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal 32
Circulating tumor cells isolation: the "post-EpCAM era" 32
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights 31
Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer 31
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer 30
An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer 30
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial 30
Sequential isolation and characterization of single CTCs and large CTC clusters in metastatic colorectal cancer patients 29
Significance of circulating tumor cells in soft tissue sarcoma 29
Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma 29
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer 29
The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells 29
Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine 28
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test 28
Coexistence of three EGFR mutations in an NSCLC patient: A brief report 28
Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy” 28
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature 28
Circulating tumor cells count and characterization in a male breast cancer patient 27
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study 27
Why the therapeutic impact of RAS mutation clearance in plasma ctDNA deserves to be further explored in metastatic colorectal cancer 26
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients 26
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma 26
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 24
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 24
EpCAM-expressing circulating tumor cells in colorectal cancer 24
EpCAMlow Circulating Tumor Cells: Gold in the Waste 24
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma 24
Liquid Biopsy for Predicting Bacillus Calmette-Guérin Unresponsiveness in Non-muscle-invasive Bladder Cancer 24
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion 24
In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity 23
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system? 22
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients 20
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis 14
Prognostic Value of Circulating Tumor Cells and Cancer Associated Macrophage-Like Cells in Metastatic Non-Small Cell Lung Cancer Patients: A Retrospective Exploratory Analysis 7
Organotropism-specific circulating tumor cells profiles: Morphology and heterotypic clustering predict metastatic sites in liquid biopsy of solid tumors 2
Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes? 2
Totale 1.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025206 0 0 0 0 0 0 14 16 22 114 31 9
2025/20261.682 167 45 300 419 154 43 39 126 143 95 77 74
2026/202752 27 25 0 0 0 0 0 0 0 0 0 0
Totale 1.940